Inhibitors of Glucosylceramide Synthase
- 1 January 2023
- book chapter
- Published by Springer Nature
- Vol. 2613, 271-288
Abstract
Glucosylceramide synthase can be targeted by high affinity small molecular weight inhibitors for the study of glycosphingolipid metabolism and function or for the treatment of glycosphingolipid storage disorders, including Gaucher and Fabry disease. This work is exemplified by the discovery and development of eliglustat tartrate, the first stand-alone small chemical entity approved for the treatment of Gaucher disease type 1. The development of inhibitors of glucosylceramide synthase that have utility for either research or clinical purposes begins with a testing funnel for screening candidate inhibitors for activity against this enzyme and for activity in lowering the content of glucosylceramide in intact cells. Two common assays for glucosylceramide synthase, one enzyme based and another cell based, are the focus of this chapter. Key words Glucosylceramide synthase UDP-glucose Ceramide Eliglustat tartrate Gaucher diseaseKeywords
This publication has 30 references indexed in Scilit:
- β-Glucosidase 2 (GBA2) Activity and Imino Sugar PharmacologyJournal of Biological Chemistry, 2013
- Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brainJournal of Lipid Research, 2012
- Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and ImigluceraseMolecular Pharmaceutics, 2011
- Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide SynthasePLOS ONE, 2010
- Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse modelsNature Medicine, 2010
- Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-β-glucosidaseBiochemical Pharmacology, 2007
- Cell Cycle Arrest Induced by an Inhibitor of Glucosylceramide SynthaseJournal of Biological Chemistry, 1995
- Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cellsJournal of Cellular Physiology, 1989
- Short chain ceramides as substrates for glucocerebroside synthetase. Differences between liver and brain enzymesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acidBiochemistry, 1969